Large clinical trial finds pirfenidone may help lung function in IPF patients
Sunday, May 17, 2009 - 12:42
in Health & Medicine
ATS 2009, SAN DIEGO?A large, well-controlled, multi-national clinical trial program has demonstrated the effectiveness and safety of what may become the first FDA-approved medicine for idiopathic pulmonary fibrosis, or IPF. In a Phase III clinical study program called "CAPACITY," investigators discovered that the oral anti-fibrotic and anti-inflammatory agent, pirfenidone, could slow the d
Read the whole article on Science Blog
More from Science Blog
Related
- Large clinical trial finds pirfenidone may help lung function in IPF patientsSun, 17 May 2009, 13:42:52 EDT
- Results from TH-302 clinical trials presented at international lung cancer meetingThu, 6 Aug 2009, 17:30:56 EDT
- A blood substitute's effectiveness and safety addressed in large clinical trialTue, 10 Jun 2008, 19:56:19 EDT
- Project Zero Delay accelerates drug's path to clinical trialMon, 3 Aug 2009, 16:24:58 EDT
- Quality assurance programs improve clinical trialsSun, 21 Sep 2008, 17:22:15 EDT